Session Time: 4:30pm-5:30pm
Presentation Time: 4:50pm-4:55pm
*Purpose: Chronic active antibody-mediated rejection (CAAMR) induced by de novo donor-specific antibodies (DSA) is the main cause of graft loss in the long-term. Currently, there is no effective treatment or predictive marker for CAAMR exists. Therefore, a reliable immunoresponse monitoring system to identify recipients who will develop CAAMR in the future is required to improve long-term allograft survival. A novel CFSE/MLR assay was developed to evaluate T cell responses in kidney transplant recipients.
*Methods: This assay was developed using isolated T cells as responders, which is much more sensitive to detect T cell responses compared with the standard MLR using PBMCs. In this study, 84 kidney transplant recipients were evaluated using this novel assay. The recipients were divided into two groups (stable; n=60, DSA+; n=24) and their T cell responses were compared.
*Results: In pathological analyses, all recipients in the stable group experienced any incidents of rejection, whereas 18 DSA+ recipients developed CAAMR and 6 DSA+ recipients still did not develop CAAMR (pre-CAAMR). The MLR assay revealed that the anti-donor CD4+/CD8+ T cell responses were significantly higher in DSA+ recipients than in stable recipients. Interestingly, in stable recipients, the anti-donor CD4+ T cell response was significantly lower than the anti-third-party response, and the donor-specific hyporesponsiveness was also observed in CD8+ T cells. In contrast, donor specific hyporesponsiveness of CD4+ T cells disappeared in DSA+ recipients. To elucidate the underlying mechanisms for DSA production, the levels of INF-γ, IL-4, IL-17 and FOXP3 in responder T cells were evaluated to identify which CD4+ T cell subsets were expanding. Proliferating CD4+ T cells showed a marked increase in the Th1 (CD4+INF-γ+) and Th17 (CD4+IL-17+) response in DSA+ recipients, whereas there was no difference in donor reactive Th2 (CD4+IL4+) and Treg (CD4+FOXP3+). Evaluation of the six pre-CAAMR recipients showed a similar CD4+ T cell landscape, suggesting that the novel MLR assay can predict the development of CAAMR.
*Conclusions: DSA+ recipients have a greater potential for immune responses against the donor tissue. CFSE/MLR using isolated T cells is a useful immunoresponse monitoring system to predict the development of CAAMR.
To cite this abstract in AMA style:Iwahara N, Hotta K, Tanabe T, Iwami D, Takada Y, Higuchi H, Sasaki H, Harada H, Shinohara N. Novel Mixed Lymphocyte Reaction Monitoring System That Predicts Chronic Antibody- Mediated Rejection in Kidney Transplant Recipients [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/novel-mixed-lymphocyte-reaction-monitoring-system-that-predicts-chronic-antibody-mediated-rejection-in-kidney-transplant-recipients/. Accessed June 16, 2021.
« Back to 2021 American Transplant Congress